LICENSE AGREEMENTS (Details)		1 Months Ended	3 Months Ended				9 Months Ended
	Apr. 28, 2021 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2023 EUR (€)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Jan. 24, 2022 USD ($)
LICENSE AGREEMENTS
Milestone payment received							$ (1,089,977)		$ 28,408,434
Revenue			$ 6,185,814		$ 1,591,566		13,089,977		$ 1,591,566
Deferred revenue, current			25,405,084				25,405,084			$ 17,980,599
Deferred revenue, net of current			953,470				953,470			$ 9,467,932
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States
LICENSE AGREEMENTS
Potential milestone payments			100,000,000.0				100,000,000.0
Upfront Payment						$ 30,000,000.0
Deferred revenue liability		$ 30,000,000.0	14,400,000			30,000,000.0	14,400,000
Revenue			6,200,000				13,100,000
Deferred revenue, current			13,400,000				13,400,000
Deferred revenue, net of current			$ 1,000,000.0				$ 1,000,000.0
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
LICENSE AGREEMENTS
Revenue, Remaining Performance Obligation, Percentage			93.00%				93.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period			3 months				3 months
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
LICENSE AGREEMENTS
Revenue, Remaining Performance Obligation, Percentage			93.00%				93.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period			12 months				12 months
Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, Japan
LICENSE AGREEMENTS
Potential milestone payments				$ 89,000,000
Upfront Payment				12,000,000.0
Milestone payment received				$ 12,000,000.0
Deferred revenue liability			$ 12,000,000.0				$ 12,000,000.0
Deferred revenue, current			12,000,000.0				$ 12,000,000.0
Rome License Agreement
LICENSE AGREEMENTS
Notice period							90 days	90 days
JHU License Agreement
LICENSE AGREEMENTS
Notice period							60 days	60 days
Milestone payments to be made upon completion of certain phases		500,000				$ 500,000
Threshold period to cure breach							30 days	30 days
CSMC License Agreement
LICENSE AGREEMENTS
Notice period							90 days	90 days
Exosomes License Agreement
LICENSE AGREEMENTS
Notice period	90 days						90 days	90 days
Upfront Payment	$ 10,000
Minimum | Rome License Agreement
LICENSE AGREEMENTS
Minimum annual royalty payments | €								€ 20,000
Maximum | Commercialization and Distribution Agreement with Nippon Shinyaku Co, Limited, United States
LICENSE AGREEMENTS
Potential milestone payments											$ 705,000,000.0
Maximum | JHU License Agreement
LICENSE AGREEMENTS
Potential milestone payments			$ 1,850,000				$ 1,850,000
Completion Of Phase Two Due | JHU License Agreement
LICENSE AGREEMENTS
Milestones paid		$ 250,000
Patent rights | JHU License Agreement
LICENSE AGREEMENTS
Agreement effective period							20 years	20 years
Patent rights | Exosomes License Agreement
LICENSE AGREEMENTS
Agreement effective period	20 years
Particular Patent or Application or Any Particular Licensed Product | Exosomes License Agreement
LICENSE AGREEMENTS
Notice period	60 days
Non Payment of Royalties | CSMC License Agreement
LICENSE AGREEMENTS
Agreement termination period							30 days	30 days
Non Payment of Royalties | Exosomes License Agreement
LICENSE AGREEMENTS
Threshold period to cure breach							30 days	30 days
CSMC Agreement Compliance | CSMC License Agreement
LICENSE AGREEMENTS
Agreement termination period							90 days	90 days
CSMC Agreement Compliance | Exosomes License Agreement
LICENSE AGREEMENTS
Threshold period to cure breach							90 days	90 days
Material Breach Has Not Been Cured | CSMC License Agreement
LICENSE AGREEMENTS
Agreement termination period							90 days	90 days
Material Breach Has Not Been Cured | Exosomes License Agreement
LICENSE AGREEMENTS
Threshold period to cure breach							90 days	90 days
Fails To Cure Breach after Notice From CSMC | CSMC License Agreement
LICENSE AGREEMENTS
Agreement termination period							90 days	90 days
Fails To Cure Breach after Notice From CSMC | Exosomes License Agreement
LICENSE AGREEMENTS
Threshold period to cure breach	60 days						90 days	90 days